Cultivated meat firm successfully trials low-cost bioreactor
Cultivated meat company Meatly has completed the first cell growth run in its pilot bioreactor that could reduce costs by as much as 95%.
Cultivated meat company Meatly has completed the first cell growth run in its pilot bioreactor that could reduce costs by as much as 95%.
